Regina R. Berkovich MD PhD
Neuroimaging, Neuroimmunology/Multiple Sclerosis
Director, Regina Berkovich MD, PhD Inc. Teaching Faculty, Neurology, LAC-USC
Join to View Full Profile
Regina Berkovich MD, PhD Inc8727 Beverly Blvd, Ste BWest Hollywood, CA 90048
Phone+1 310-474-9595
Fax+1 866-737-9505
Dr. Berkovich is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Regina Berkovich is an MS and NMOSD expert neurologist in West Hollywood, CA; affiliated with USC (Teaching Faculty) and LAC+USC (Attending Neurologist). MD: Kazan State Medical University, 1991; PhD: Clinical Pharmacology 1996. Expertise: MS, NMOSD, other CNS inflammatory conditions and neurosarcioidosis; MS and NMO Relapses; Symptomatic therapy (Botox); PI of many clinical trials, incl. IITs
Education & Training
Kazan State Medical UniversityClass of 1991
University Kazan State Medical UniversityBachelor's, 1991
Certifications & Licensure
CA State Medical License 2008 - 2028
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification PowerChart (CQM), Cerner Corporation, 2015-2017
- CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2017
Clinical Trials
- Pulse ACTH vs. MP for MS Start of enrollment: 2009 Nov 01
- A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab Start of enrollment: 2019 Jul 03
- A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2) Start of enrollment: 2019 Jul 22
Roles: Principal Investigator
Publications & Presentations
PubMed
- Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants.Ralf Gold, Krzysztof W Selmaj, Regina Berkovich, Jeffrey A Cohen, Giancarlo Comi
Annals of Clinical and Translational Neurology. 2026-03-27 - A Narrative Review of the Immunomodulatory Effects of ActharGel Beyond Its Steroidogenic Properties.Mehdi Mirsaeidi, Jeffrey Kaplan, John Affeldt, Regina Berkovich, Anca Askanase
Advances in Therapy. 2025-11-01 - Effectiveness of teriflunomide in patients with relapsing multiple sclerosis who switched from other disease-modifying therapies.Regina Berkovich, Nupur Greene, Sheila R Reddy, Eunice Chang, Marian H Tarbox
Medicine. 2025-10-17
Journal Articles
- Intravenous Dextromethorphan/Quinidine Inhibits Activity of Dura-sensitive Spinal Trigeminal Neurons in RatsBerkovich R., Sokolov A., Lyubashina O, European Journal of Pain, 1/1/2014
- Intravenous Valproate Inhibits Ongoing and Evoked Activity of Dura-sensitive Thalamic Neurons in RatsSokolov AY, Lyubashina OA, Sivachenko IB, Berkovich RR, Panteleev SS, Eur J Pharmacol, 1/31/2013
- Therapeutic Mechanisms of Action of Adrenocorticotropic Hormone (ACTH) And Other Melanocortin Peptides for the Clinical Management of Patients with MSArnason B, Berkovich R, Catania A. et al., Mult Scler, 1/1/2013
Books/Book Chapters
Abstracts/Posters
- Pilot Study of Monthly Pulse Adrenocorticotropic Hormone (ACTH) Or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple Scle...Berkovich R, Amezcua L, Subhani D, Cen S, American Academy of Neurology's 65th Annual Meeting, San Diego, CA, 1/16/2013
- Pilot Study of Monthly Pulse Adrenocorticotropic Hormone or Methylprednisolone as an Add-on Therapy to Beta-interferons for Long-term Treatment of Multiple SclerosisAmezcua L, Axtell R, Cen S, Tauhid S; Neema M, Subhani D, Bakshi R, Steinman L and Berkovich R, 29th European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 1/2/2013
- Dynamics of the Peripheral Blood CD4 Cell Counts of JCV Ab Positive Patients at the Different Phases of Natalizumab TreatmentBerkovich R, Togasaki D, Subhani D, Steinman L, ECTRIMS, Lyon, France, 1/12/2012
Lectures
- Clinical Experience with Aubagio [Launching of Aubagio in Russian Federation]Yaroslavl, Russia - 1/24/2014
- Immunomodulatory Treatment Options for Multiple SclerosisOregon - 1/17/2014
- Clinical Experience with Aubagio. [Launching of Aubagio in European Union]Brussels, Belgium - 1/12/2014
Other
- Multiple Sclerosis: Treatment of Its SymptomsBerkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
http://www.medlink.com
San Diego - 1/4/2013 - Immunomodulatory Agents in MS: Clinical Trials and TherapyBerkovich R, Kantor D, Reder AT, MedLink Neurology, MedLink Corporation
http://www.medlink.com
San Diego - 1/10/2002
Authored Content
- Late Breakers Review of FENtrepid and PERSEUS for the Treatment of Primary Progressive Multiple Sclerosis (PPMS)February 2026
Press Mentions
Regina R. Berkovich, MD, PhD, a Neurologist with Medical Imaging Center of Southern CaliforniaDecember 12th, 2019
A New Treatment Option for People with Multiple Sclerosis on Coast LiveJuly 24th, 2019
IV Hydrogen Peroxide: An Unproven Therapy That Could Be DangerousSeptember 5th, 2017
Other Languages
- Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
